Advance Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Advance Capital Management's PFE Position: Q1 2026 in Review
Advance Capital Management increased its Pfizer (PFE) stake by 40% in Q1 2026, buying an estimated $92.8K and bringing the position to 12,215 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #131.
Advance Capital Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $622K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Advance Capital Management held 12,215 shares of Pfizer worth $343K as of Q1 2026.
- Advance Capital Management bought 3,486 Pfizer shares in Q1 2026, an estimated $92.8K.
- Pfizer made up 0.01% of Advance Capital Management's portfolio in Q1 2026, its #131 holding.
- Advance Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Advance Capital Management's Pfizer position peaked at $622K in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Advance Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.